WebMD Health (WBMD) Names Blake DeSimone CFO; Sees Q3, FY Results at High End of Guidance
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
WebMD Health Corp. (NASDAQ WBMD) announced that the Board of Directors has appointed Blake DeSimone, its Senior Vice President of Finance, as its Chief Financial Officer. Mr. DeSimone succeeds Peter Anevski who is leaving the Company.
Mr. DeSimone, 40, joined WebMD as its Senior Vice President of Finance in June 2015. In that role, he has been responsible for the Company's SEC and financial reporting, financial planning and analysis, and treasury management. Prior to joining WebMD, Mr. DeSimone was Chief Financial Officer of D+M Holdings, a global consumer electronics company that had approximately $500 million of annual revenue during his tenure. Prior to that, he was President and CFO of Advogent Group, Inc., a services company providing sales and marketing support to the healthcare industry. He also served in other executive roles at Cardinal Health and Boron Lepore & Associates, Inc. Mr. DeSimone is a Certified Public Accountant and started his career in Arthur Andersen's Assurance Practice.
Steven L. Zatz, M.D., Chief Executive Officer of WebMD, said "I congratulate Blake on his promotion. Over the past year, I have had the opportunity to work closely with Blake, who has been a strong leader in our finance organization. Blake provides a unique combination of financial, operational and healthcare experience that will be of great value to the Company in his new role." Dr. Zatz added, "We thank Pete for his many contributions during his tenure with the Company and wish him well in his future endeavors."
"I am excited to have this opportunity to become WebMD's Chief Financial Officer," said Mr. DeSimone. "We have a strong finance organization and I expect my transition to be seamless. I look forward to working closely with Steve to drive the future growth of WebMD."
WebMD also announced today that it expects its financial results for the third quarter and full year of 2016 to be around the high end of its financial guidance issued on August 8, 2016. That financial guidance and this reaffirmation do not reflect the impact of deployment of capital for items such as share repurchases, convertible note repurchases or acquisitions, gains or losses from discontinued operations, or other non-recurring, one-time or unusual items in the quarters for which guidance was provided, including stock repurchases and severance related to recent management changes in the third quarter of 2016.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- China Biologic Products (CBPO) Announces Acquisition of Full Guizhou Taibang Ownership
- Collegium Pharma (COLL) Prices 5M Share Stock Offering for Proceeds of $80M
- Vonage (VG) Tops Q3 EPS by 4c
Create E-mail Alert Related CategoriesCorporate News, Guidance, Management Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!